Study : Remdesivir drug has negligible treatment benefit for moderate Covid-19 patients
According to a new study, after taking a 5-day course of Remdesivir drug manufactured by Gilead Sciences Inc, condition of moderately ill Covid-19 patients started to improve. These patients were…